MedPath

Modification of Jivantyadi Yamaka into Malahara and its Clinical Efficacy in Psoriasis

Not Applicable
Completed
Conditions
Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
Registration Number
CTRI/2021/04/032979
Lead Sponsor
Government Ayurved Hospital Vadodara
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Patients with all forms of Ekakushtha (Psoriasis) with classical signs & symptoms of Ekakushtha (Psoriasis)

All type of psoriasis will be included

Less than 20 % involved area according to PASI guidelines

Exclusion Criteria

More than 20 % involved area according to PASI guidelines

Age <18yrs and >60yrs.

Pregnant women and lactating mother

Uncontrolled Diabetes Mellitus & Hypertension

Any other serious systemic illness like AIDS, Malignancy etc

�Patients who are not willing to be included in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in the Classical Symptoms of Ekakushtha (Psoriasis)Timepoint: 35 days
Secondary Outcome Measures
NameTimeMethod
Difference in Clinical efficacy of Jivantyadi Yamaka and Malahara in Ekakushtha (Psoriasis)Timepoint: 35 days
© Copyright 2025. All Rights Reserved by MedPath